These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

468 related items for PubMed ID: 17203233

  • 1. An imbalance between Smad and MAPK pathways is responsible for TGF-beta tumor promoting effects in high-grade gliomas.
    Nickl-Jockschat T, Arslan F, Doerfelt A, Bogdahn U, Bosserhoff A, Hau P.
    Int J Oncol; 2007 Feb; 30(2):499-507. PubMed ID: 17203233
    [Abstract] [Full Text] [Related]

  • 2. Cooperation of H2O2-mediated ERK activation with Smad pathway in TGF-beta1 induction of p21WAF1/Cip1.
    Kim YK, Bae GU, Kang JK, Park JW, Lee EK, Lee HY, Choi WS, Lee HW, Han JW.
    Cell Signal; 2006 Feb; 18(2):236-43. PubMed ID: 15979845
    [Abstract] [Full Text] [Related]

  • 3. Transforming growth factor beta signaling via Ras in mesenchymal cells requires p21-activated kinase 2 for extracellular signal-regulated kinase-dependent transcriptional responses.
    Suzuki K, Wilkes MC, Garamszegi N, Edens M, Leof EB.
    Cancer Res; 2007 Apr 15; 67(8):3673-82. PubMed ID: 17440079
    [Abstract] [Full Text] [Related]

  • 4. Induction of transforming growth factor-beta1 by basic fibroblast growth factor in rat C6 glioma cells and astrocytes is mediated by MEK/ERK signaling and AP-1 activation.
    Dhandapani KM, Khan MM, Wade FM, Wakade C, Mahesh VB, Brann DW.
    J Neurosci Res; 2007 Apr 15; 85(5):1033-45. PubMed ID: 17335076
    [Abstract] [Full Text] [Related]

  • 5. SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo.
    Uhl M, Aulwurm S, Wischhusen J, Weiler M, Ma JY, Almirez R, Mangadu R, Liu YW, Platten M, Herrlinger U, Murphy A, Wong DH, Wick W, Higgins LS, Weller M.
    Cancer Res; 2004 Nov 01; 64(21):7954-61. PubMed ID: 15520202
    [Abstract] [Full Text] [Related]

  • 6. Aryl hydrocarbon receptor inhibition downregulates the TGF-beta/Smad pathway in human glioblastoma cells.
    Gramatzki D, Pantazis G, Schittenhelm J, Tabatabai G, Köhle C, Wick W, Schwarz M, Weller M, Tritschler I.
    Oncogene; 2009 Jul 16; 28(28):2593-605. PubMed ID: 19465936
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of RhoA/Rho-kinase pathway suppresses the expression of type I collagen induced by TGF-beta2 in human retinal pigment epithelial cells.
    Itoh Y, Kimoto K, Imaizumi M, Nakatsuka K.
    Exp Eye Res; 2007 Mar 16; 84(3):464-72. PubMed ID: 17217948
    [Abstract] [Full Text] [Related]

  • 8. Transforming growth factor (TGF)-beta1-induced human endometrial stromal cell decidualization through extracellular signal-regulated kinase and Smad activation in vitro: peroxisome proliferator-activated receptor gamma acts as a negative regulator of TGF-beta1.
    Chang HJ, Lee JH, Hwang KJ, Kim MR, Chang KH, Park DW, Min CK.
    Fertil Steril; 2008 Oct 16; 90(4 Suppl):1357-65. PubMed ID: 18082740
    [Abstract] [Full Text] [Related]

  • 9. Crosstalk mechanisms between the mitogen-activated protein kinase pathways and Smad signaling downstream of TGF-beta: implications for carcinogenesis.
    Javelaud D, Mauviel A.
    Oncogene; 2005 Aug 29; 24(37):5742-50. PubMed ID: 16123807
    [Abstract] [Full Text] [Related]

  • 10. Platelet-derived growth factor and transforming growth factor-beta modulate the expression of matrix metalloproteinases and migratory function of human airway smooth muscle cells.
    Ito I, Fixman ED, Asai K, Yoshida M, Gounni AS, Martin JG, Hamid Q.
    Clin Exp Allergy; 2009 Sep 29; 39(9):1370-80. PubMed ID: 19522858
    [Abstract] [Full Text] [Related]

  • 11. Mutant p53 attenuates the SMAD-dependent transforming growth factor beta1 (TGF-beta1) signaling pathway by repressing the expression of TGF-beta receptor type II.
    Kalo E, Buganim Y, Shapira KE, Besserglick H, Goldfinger N, Weisz L, Stambolsky P, Henis YI, Rotter V.
    Mol Cell Biol; 2007 Dec 29; 27(23):8228-42. PubMed ID: 17875924
    [Abstract] [Full Text] [Related]

  • 12. Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway.
    Yamashita M, Otsuka F, Mukai T, Otani H, Inagaki K, Miyoshi T, Goto J, Yamamura M, Makino H.
    J Endocrinol; 2008 Mar 29; 196(3):601-13. PubMed ID: 18310456
    [Abstract] [Full Text] [Related]

  • 13. Cross talk among Smad, MAPK, and integrin signaling pathways enhances adventitial fibroblast functions activated by transforming growth factor-beta1 and inhibited by Gax.
    Liu P, Zhang C, Feng JB, Zhao YX, Wang XP, Yang JM, Zhang MX, Wang XL, Zhang Y.
    Arterioscler Thromb Vasc Biol; 2008 Apr 29; 28(4):725-31. PubMed ID: 18187669
    [Abstract] [Full Text] [Related]

  • 14. Substantial changes in gene expression of Wnt, MAPK and TNFalpha pathways induced by TGF-beta1 in cervical cancer cell lines.
    Kloth JN, Fleuren GJ, Oosting J, de Menezes RX, Eilers PH, Kenter GG, Gorter A.
    Carcinogenesis; 2005 Sep 29; 26(9):1493-502. PubMed ID: 15878915
    [Abstract] [Full Text] [Related]

  • 15. [Regulatory effect of Smad7 gene on MAPK signal pathway in malignant transformation of immortalized human bronchial epithelial BEP2D cells].
    Wang L, Huo YY, Zhang KT, Wang Y, Xiang XQ, Hu YC, Yu G, Li G, Mi C, Wu DC.
    Ai Zheng; 2005 Sep 29; 24(9):1080-4. PubMed ID: 16159429
    [Abstract] [Full Text] [Related]

  • 16. Upregulation of ID protein by growth and differentiation factor 5 (GDF5) through a smad-dependent and MAPK-independent pathway in HUVSMC.
    Chen X, Zankl A, Niroomand F, Liu Z, Katus HA, Jahn L, Tiefenbacher C.
    J Mol Cell Cardiol; 2006 Jul 29; 41(1):26-33. PubMed ID: 16716349
    [Abstract] [Full Text] [Related]

  • 17. Oncogenic Ras blocks transforming growth factor-beta-induced cell-cycle arrest by degradation of p27 through a MEK/Erk/SKP2-dependent pathway.
    Schepers H, Wierenga AT, Eggen BJ, Vellenga E.
    Exp Hematol; 2005 Jul 29; 33(7):747-57. PubMed ID: 15963850
    [Abstract] [Full Text] [Related]

  • 18. Overactivation of the MEK/ERK pathway in liver tumor cells confers resistance to TGF-{beta}-induced cell death through impairing up-regulation of the NADPH oxidase NOX4.
    Caja L, Sancho P, Bertran E, Iglesias-Serret D, Gil J, Fabregat I.
    Cancer Res; 2009 Oct 01; 69(19):7595-602. PubMed ID: 19773433
    [Abstract] [Full Text] [Related]

  • 19. Smad4 silencing in pancreatic cancer cell lines using stable RNA interference and gene expression profiles induced by transforming growth factor-beta.
    Jazag A, Ijichi H, Kanai F, Imamura T, Guleng B, Ohta M, Imamura J, Tanaka Y, Tateishi K, Ikenoue T, Kawakami T, Arakawa Y, Miyagishi M, Taira K, Kawabe T, Omata M.
    Oncogene; 2005 Jan 20; 24(4):662-71. PubMed ID: 15592526
    [Abstract] [Full Text] [Related]

  • 20. TGF-beta induces connexin43 gene expression in normal murine mammary gland epithelial cells via activation of p38 and PI3K/AKT signaling pathways.
    Tacheau C, Fontaine J, Loy J, Mauviel A, Verrecchia F.
    J Cell Physiol; 2008 Dec 20; 217(3):759-68. PubMed ID: 18668519
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.